NASDAQ:QNRX | Insider Transactions | Quoin Pharmaceuticals, Ltd.

QNRX Insider Transactions

19 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 1–19; provenance stays internal.

QNRX insiders transaction timeline

PurchaseSale
2024-06-07: 1 sale — LANGER DENNIS2024-09-03: 3 purchases — Carter Denise P., Myers Michael2024-09-04: 5 purchases — Carter Denise P., Myers Michael2024-09-09: 3 purchases — Dunn Gordon2024-09-10: 2 purchases — Dunn Gordon2024-12-23: 4 purchases — Carter Denise P., Myers Michael, Dunn Gordon and 1 more2025-10-14: 1 purchase — LANGER DENNIS2024-06-072025-10-14
Insider profileRoleDateTransactionSharesPrice
LANGER DENNISDirector2025-10-14Purchase15,152.0$8.49
Carter Denise P.Chief Operating Officer2024-12-23Purchase555,556.0$0.45
Myers MichaelChief Executive Officer2024-12-23Purchase555,556.0$0.45
Dunn GordonChief Financial Officer2024-12-23Purchase122,221.0$0.45
Culverwell Anthony JamesDirector2024-12-23Purchase100,000.0$0.45
Dunn GordonChief Financial Officer2024-09-10Purchase10,000.0$0.71
Dunn GordonChief Financial Officer2024-09-10Purchase10,000.0$0.91
Dunn GordonChief Financial Officer2024-09-09Purchase4,000.0$0.8
Dunn GordonChief Financial Officer2024-09-09Purchase4,000.0$0.78
Dunn GordonChief Financial Officer2024-09-09Purchase856.0$0.8
Carter Denise P.Chief Operating Officer2024-09-04Purchase22,988.0$0.8
Carter Denise P.Chief Operating Officer2024-09-04Purchase8,825.0$0.75
Myers MichaelChief Executive Officer2024-09-04Purchase23,572.0$0.8
Myers MichaelChief Executive Officer2024-09-04Purchase8,200.0$0.75
Myers MichaelChief Executive Officer2024-09-04Purchase5,322.0$0.66
Carter Denise P.Chief Operating Officer2024-09-03Purchase4,100.0$0.66
Carter Denise P.Chief Operating Officer2024-09-03Purchase1,822.0$0.63
Myers MichaelChief Executive Officer2024-09-03Purchase800.0$0.62
LANGER DENNISDirector2024-06-07Sale297.0$0.73